TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data - PubMed (original) (raw)
doi: 10.1002/humu.23035. Epub 2016 Jul 8.
Affiliations
- PMID: 27328919
- DOI: 10.1002/humu.23035
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al. Hum Mutat. 2016 Sep.
Abstract
TP53 gene mutations are one of the most frequent somatic events in cancer. The IARC TP53 Database (http://p53.iarc.fr) is a popular resource that compiles occurrence and phenotype data on TP53 germline and somatic variations linked to human cancer. The deluge of data coming from cancer genomic studies generates new data on TP53 variations and attracts a growing number of database users for the interpretation of TP53 variants. Here, we present the current contents and functionalities of the IARC TP53 Database and perform a systematic analysis of TP53 somatic mutation data extracted from this database and from genomic data repositories. This analysis showed that IARC has more TP53 somatic mutation data than genomic repositories (29,000 vs. 4,000). However, the more complete screening achieved by genomic studies highlighted some overlooked facts about TP53 mutations, such as the presence of a significant number of mutations occurring outside the DNA-binding domain in specific cancer types. We also provide an update on TP53 inherited variants including the ones that should be considered as neutral frequent variations. We thus provide an update of current knowledge on TP53 variations in human cancer as well as inform users on the efficient use of the IARC TP53 Database.
Keywords: TP53; annotations; cancer; germline variations; locus-specific database; mutation hotspots; somatic mutations.
© 2016 WILEY PERIODICALS, INC.
Similar articles
- Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Petitjean A, et al. Hum Mutat. 2007 Jun;28(6):622-9. doi: 10.1002/humu.20495. Hum Mutat. 2007. PMID: 17311302 - The IARC TP53 database: new online mutation analysis and recommendations to users.
Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. Olivier M, et al. Hum Mutat. 2002 Jun;19(6):607-14. doi: 10.1002/humu.10081. Hum Mutat. 2002. PMID: 12007217 - TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
Li VD, Li KH, Li JT. Li VD, et al. J Cancer Res Clin Oncol. 2019 Mar;145(3):625-636. doi: 10.1007/s00432-018-2817-z. Epub 2018 Dec 12. J Cancer Res Clin Oncol. 2019. PMID: 30542790 - TP53 mutations in human cancer: database reassessment and prospects for the next decade.
Soussi T. Soussi T. Adv Cancer Res. 2011;110:107-39. doi: 10.1016/B978-0-12-386469-7.00005-0. Adv Cancer Res. 2011. PMID: 21704230 Review. - TP53 mutations in human cancer: database reassessment and prospects for the next decade.
Leroy B, Anderson M, Soussi T. Leroy B, et al. Hum Mutat. 2014 Jun;35(6):672-88. doi: 10.1002/humu.22552. Hum Mutat. 2014. PMID: 24665023 Review.
Cited by
- From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.
Ahmadi SE, Rahimian E, Rahimi S, Zarandi B, Bahraini M, Soleymani M, Safdari SM, Shabannezhad A, Jaafari N, Safa M. Ahmadi SE, et al. Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9. Biomark Res. 2024. PMID: 39538363 Free PMC article. Review. - Drosophila p53 tumor suppressor directly activates conserved asymmetric stem cell division regulators.
Manzanero-Ortiz S, Franco M, Laxmeesha M, Carmena A. Manzanero-Ortiz S, et al. iScience. 2024 Oct 9;27(11):111118. doi: 10.1016/j.isci.2024.111118. eCollection 2024 Nov 15. iScience. 2024. PMID: 39524346 Free PMC article. - The molecular genetics of adrenal cushing.
Vaduva P, Bertherat J. Vaduva P, et al. Hormones (Athens). 2024 Dec;23(4):601-610. doi: 10.1007/s42000-024-00608-0. Epub 2024 Oct 10. Hormones (Athens). 2024. PMID: 39388056 Review. - Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants.
Lo CS, Alavi P, Bassey-Archibong B, Jahroudi N, Pasdar M. Lo CS, et al. PLoS One. 2024 Oct 3;19(10):e0306705. doi: 10.1371/journal.pone.0306705. eCollection 2024. PLoS One. 2024. PMID: 39361615 Free PMC article. - Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma.
Kurihara Y, Honda T, Takemoto A, Seto K, Endo S, Tanimoto K, Kirimura S, Kobayashi M, Baba S, Nakashima Y, Wakejima R, Sakakibara R, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K. Kurihara Y, et al. JTCVS Open. 2024 Jun 14;20:183-193. doi: 10.1016/j.xjon.2024.06.005. eCollection 2024 Aug. JTCVS Open. 2024. PMID: 39296452 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous